Trial intelligence / Profile preview

Effect of Hylodoid ointment (heparinoid) on APTT

jRCT1030250478Completed

Sponsor
Nothing in particular
Start
Nov 2025
Countries
1
01

Overview

Open-label, single-arm trial of mucopolysaccharide polysulphate, sponsored by Nothing in particular. Primary endpoint: Activated partial thromboplastin time (APTT). Started Nov 2025; status: completed.

02

Drugs

mucopolysaccharide polysulphate

Beyond the preview

Go deeper on jRCT1030250478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1030250478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call